# Neurocrine Biosciences Inc. (NBIX) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | $619M |
| 2024 | $571M |
| 2023 | $251M |
| 2022 | $249M |
| 2021 | $103M |
| 2020 | $163M |
| 2019 | $72M |
| 2018 | $37M |
| 2017 | -$131M |
| 2016 | -$147M |
| 2015 | -$94M |
| 2014 | -$64M |
| 2013 | -$50M |
| 2012 | $1M |
| 2011 | $34M |
| 2010 | -$14M |
| 2009 | -$54M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | $193M |
| 2025-09-30 | $239M |
| 2025-06-30 | $146M |
| 2025-03-31 | $24M |
| 2024-09-30 | $184M |
| 2024-06-30 | $145M |
| 2024-03-31 | $99M |
| 2023-09-30 | $141M |
| 2023-06-30 | $74M |
| 2023-03-31 | -$114M |
| 2022-09-30 | $88M |
| 2022-06-30 | $55M |
| 2022-03-31 | $3M |
| 2021-09-30 | $45M |
| 2021-06-30 | $63M |
| 2021-03-31 | $32M |
| 2020-09-30 | -$44M |
| 2020-06-30 | $77M |
| 2020-03-31 | $59M |
| 2019-09-30 | $90M |
| 2019-06-30 | $34M |
| 2019-03-31 | -$101M |
| 2018-09-30 | $54M |
| 2018-06-30 | -$2M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/NBIX/operating-income)